MedPath

Nyamyc

Nyamyc® (Nystatin Topical Powder, USP)

Approved
Approval ID

f4c2628e-6faa-5a0a-e053-2a95a90a9114

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 15, 2023

Manufacturers
FDA

RedPharm Drug, Inc

DUNS: 828374897

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Nystatin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code67296-1860
Application NumberANDA065183
Product Classification
M
Marketing Category
C73584
G
Generic Name
Nystatin
Product Specifications
Route of AdministrationTOPICAL
Effective DateFebruary 15, 2023
FDA Product Classification

INGREDIENTS (2)

TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
NYSTATINActive
Quantity: 100000 [USP'U] in 1 g
Code: BDF1O1C72E
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.